Compare CDMOs with EMA GMP certification for EU-market pharmaceutical manufacturing. Filter by product type, member state, and manufacturing capabilities.
349 companies listed
EMA (European Medicines Agency) GMP certification confirms that a manufacturing facility complies with EU Good Manufacturing Practice standards. GMP inspections are conducted by national competent authorities (e.g., BfArM in Germany, ANSM in France, MHRA in the UK) and the resulting GMP certificates are recognized across the EU through mutual recognition.
The EMA maintains Mutual Recognition Agreements with regulatory agencies in the US, Canada, Australia, Japan, Switzerland, and other countries. This means EU GMP inspections may be accepted by these agencies without re-inspection, reducing the regulatory burden on CDMOs serving multiple markets. The Qualified Person (QP) system -- unique to the EU -- provides an additional layer of batch release oversight.
India
C2 PHARMA is a European pharmaceutical group established in 2014 that manufactures and distributes active pharmaceutical ingredients (APIs) and complex chemical compounds from natural and synthetic origins. The company specializes in ophthalmic and niche APIs with headquarters in Cork, Ireland.
Germany
celares GmbH is a German CDMO focused on the development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. The company specializes in PEGylation technology and conjugate vaccine development, with collaborations including EMD Millipore and NOF Corporation. celares has been acquired by Biosynth, which expanded its capabilities into conjugate vaccines and bioconjugation services.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.